I-Mab Biopharma
IMAB
$1.76
Share price
0.00%
Change (1 day)
-43.97%
Change (1 year)
Categories
I-Mab Biopharma (IMAB) - Total debt
Total debt on the balance sheet as of June 2023 : $10.71 M
According to I-Mab Biopharma's latest financial reports the company's total debt is $10.71 M. A company’s total debt is the sum of all current and non-current debts.
I-Mab Biopharma - Total debt on balance sheet (from 2018 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $10.87 M | -38.39% |
| 2021-12-31 | $17.64 M | 746.35% |
| 2020-12-31 | $2.08 M | -89.01% |
| 2019-12-31 | $18.96 M | -11.28% |
| 2018-12-31 | $21.37 M | -34.7% |
| 2017-12-31 | $32.74 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | $0.32 B | 2,947.93% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | N/A | N/A | 🇺🇸 USA |